David Rodman

David Rodman is the founder of Mineralys Therapeutics. Mineralys Therapeutics has raised $328M in total funding. Latest round: Series A.

About David Rodman

David Rodman is the Chief Medical Officer (CMO) of Mineralys Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for hypertension. He joined the company shortly after its Series A funding round in April 2021. As CMO, Rodman oversees the advancement of MLS-101 through Phase 2 and pivotal trial development.

David Rodman at a glance

More founders in Philadelphia, PA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library